Symbol="RIGL"
AssetType="Common Stock"
Name="Rigel Pharmaceuticals Inc"
Description="Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California."
CIK="1034842"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="201454000"
EBITDA="-36619000"
PERatio="None"
PEGRatio="-0.1"
BookValue="-0.161"
DividendPerShare="0"
DividendYield="0"
EPS="-0.26"
RevenuePerShareTTM="0.699"
ProfitMargin="-0.312"
OperatingMarginTTM="-0.312"
ReturnOnAssetsTTM="-0.193"
ReturnOnEquityTTM="-6.99"
RevenueTTM="121144000"
GrossProfitTTM="53721000"
DilutedEPSTTM="-0.26"
QuarterlyEarningsGrowthYOY="0.745"
QuarterlyRevenueGrowthYOY="-0.132"
AnalystTargetPrice="4.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.556"
PriceToBookRatio="31.64"
EVToRevenue="1.692"
EVToEBITDA="-1.948"
Beta="0.688"
num_52WeekHigh="2.04"
num_52WeekLow="0.668"
num_50DayMovingAverage="1.385"
num_200DayMovingAverage="1.31"
SharesOutstanding="173667000"
DividendDate="None"
ExDividendDate="None"
symbol="RIGL"
open="1.15"
high="1.19"
low="1.13"
price="1.16"
volume="964043.00"
latest_trading_day="2023-08-11"
previous_close="1.17"
change="-0.01"
change_percent="-0.8547%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="33"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="1936334"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="522"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
